Literature DB >> 18430327

Isolated calcaneal metastasis from prostate cancer.

Sachin Agrawal1, Allan Irvine, Julian Money-Kyrle, Brian W Ellis.   

Abstract

We report the first case of an isolated calcaneal metastasis from prostate cancer. This case highlights the importance of considering metastatic disease in patients with persistent bone pain in the presence of known cancer, however unusual the site.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18430327      PMCID： PMC2430443          DOI： 10.1308/147870808X257265

Source DB:  PubMed          Journal:  Ann R Coll Surg Engl        ISSN： 0035-8843            Impact factor:   1.891


  4 in total

1.  Metastatic tumors of the foot.

Authors:  K K Wu; E R Guise
Journal:  South Med J       Date:  1978-07       Impact factor: 0.954

2.  Solitary calcaneal metastasis as the first sign of gastric cancer. A case report.

Authors:  D Bergqvist; J Mattsson
Journal:  Ups J Med Sci       Date:  1978       Impact factor: 2.384

Review 3.  Metastatic breast carcinoma to the os calcis presenting as heel pain.

Authors:  D M Freedman; R C Henderson
Journal:  South Med J       Date:  1995-02       Impact factor: 0.954

4.  Prevalence of latent prostate carcinoma in two U.S. populations.

Authors:  J M Guileyardo; W D Johnson; R A Welsh; K Akazaki; P Correa
Journal:  J Natl Cancer Inst       Date:  1980-08       Impact factor: 13.506
  4 in total
  3 in total

1.  Oligometastatic prostate cancer to the navicular bone: case report.

Authors:  Diane K Reyes; James A Miller; Rebecca A Cerrato; Kenneth J Pienta
Journal:  Urol Case Rep       Date:  2015-05-01

2.  An Interesting Case of Unknown Primary Presenting as Heel Pain.

Authors:  Mudalsha Ravina; Vishwa Dipak Tripathi; Amarkant Mishra; Sheikh Owais Ahmad; Shubhi Agarwal
Journal:  Indian J Nucl Med       Date:  2017 Jul-Sep

Review 3.  Metatarsal metastasis from clear cell renal cell carcinoma: a case report and literature review.

Authors:  Hongzeng Wu; Ruoqi Han; Qianqian Zhang; Yi Zhao; Helin Feng
Journal:  BMC Urol       Date:  2020-02-24       Impact factor: 2.264
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.